CKD Corporation
Notice Regarding Transition to a Company with an Audit and Supervisory Committee
CKD Corporation plans to transition to a company with an audit and supervisory committee, subject to approval at the 106th Annual General Meeting of Shareholders scheduled for June 2026, aiming to strengthen corporate governance and accelerate management decision-making.
Key Figures
- Scheduled Transition Timing: 106th Annual General Meeting of Shareholders scheduled for June 2026
- Resolution Date for Transition to a Company with an Audit and Supervisory Committee: 2026-03-27
- Representative: President & CEO Katsuhito Okuoka
AI要約
Overview of the Transition to a Company with an Audit and Supervisory Committee
CKD Corporation has resolved to transition to a company with an audit and supervisory committee, subject to approval at the 106th Annual General Meeting of Shareholders scheduled for June 2026. The purpose of this transition is to strengthen the supervisory functions of the Board of Directors by including audit and supervisory committee members as directors, thereby enhancing corporate governance. Additionally, delegating important business execution decisions from the Board of Directors to individual directors aims to promote faster management decision-making.
Future Plans and Additional Information
Details regarding amendments to the Articles of Incorporation and executive appointments related to the transition will be announced once decided. After approval at the shareholders' meeting, the transition to a company with an audit and supervisory committee will be formalized, aiming to enhance corporate value. Investors should closely monitor forthcoming disclosure information.
CKD Corporation
Company overview · Stock price · Financial data · All IR
